Intellia Therapeutics secures $400M loan facility (NTLA:NASDAQ)
· seekingalpha.com
Intellia (NTLA) secures a $400M OrbiMed term loan to fund lonvo-z development and planned U.S. HAE launch.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...